Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Study Type: Interventional"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=sars-cov-2&type=AllFields&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22
/vufind/Search/Results?lookfor=sars-cov-2&type=AllFields&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22
Search /vufind/Search2/Results?lookfor=sars-cov-2&type=AllFields&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22
PubPharm (4.622)
1
CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19) : CATCH-UP Vaccines: Extension of Community - Engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines : A Multi-Part, Phase 3, Randomized, Observer Blinded Study to Evaluate the Safety and Immunogenicity of Omicron Subvariant and Bivalent SARS-CoV-2 rS Vaccines in Adults Previously Vaccinated With Other COVID-19 Vaccines
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell) : A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell) for the Prevention of SARS-CoV-2 Infection in a Population of 18 Years of Age and Older.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Multi-systemic Rehabilitative Interventions in Long COVID-19 Patients in Two Different Settings: a Randomized Controlled Trial : Valutazione Degli Esiti a Medio-lungo Termine Della Sindrome Long Covid in Pazienti Trattati Con un Protocollo di Riabilitazione in Ambiente Termale o in Teleriabilitazione
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines : A Phase 1/2 Study of Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults : Randomized, Observer-Blind, Active-Controlled, Clinical Trial to Assess the Immunogenicity of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir) : Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome : A Phase 2 Study Evaluating the Bispecific CD3xCD20 Antibody GLOfitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (CHOP) in Patients With RIchter Syndrome as Frontline therapY
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age : A Phase 3 Randomized, Observer-Blind, Study to Evaluate Safety, Tolerability, and Immunogenicity of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus (RSV), When Given Alone or Coadministered With a Seasonal Influenza Vaccine or SARS-CoV-2 Vaccine and When Given as an Open-label Boost at 1 Year Following a Primary Dose in Adults ≥ 50 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. : A PHASE 3, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A COMBINED MODIFIED RNA VACCINE CANDIDATE AGAINST COVID-19 AND INFLUENZA IN HEALTHY INDIVIDUALS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[463]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Study Type: Interventional
Medienart
4.622
Aufsätze
4.622
E-Artikel
4.622
E-Ressourcen
Zeitschriftentitel
2.642
ClinicalTrials.gov
1.980
WHO International Clinical Trials Registry Plat...
Thema
4.622
610
Study Type: Interventional
1.498
Recruitment Status: Completed
1.471
COVID-19
1.042
Phase: Phase 2
920
Recruitment Status: Recruiting
871
Recruitment Status: Not yet recruiting
774
Phase: Phase 3
440
Recruitment Status: Authorised-recruitment may ...
355
Phase: Phase 1
324
Phase: Phase 4
312
Recruitment Status: Active, not recruiting
297
Medical Condition: COVID-19
258
Coronavirus Infections
224
Recruitment Status: Terminated
190
Medical Condition: Covid19
175
Infections
172
Severe Acute Respiratory Syndrome
164
Recruitment Status: Withdrawn
154
Pneumonia
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4.620
2020-
2
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
4.516
Englisch
94
Unbestimmt
4
Französisch
2
Galizisch
2
Deutsch
2
Italienisch
2
Spanisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...